Govt To Monitor Prices Of Vaccines In Open Market

NEW DELHI : The government is working out a mechanism to monitor the prices of anti-Covid vaccines in the open market once the jabs are available for people above 18 years of age from May 1. While vaccine companies are free to price the vaccines supplied in the open market, hospitals and other vaccine providers are likely to charge an additional fee over it.

The government plans to come out with a mechanism to keep a check on these prices even as prices will be initially governed by market dynamics, officials said.

From May 1, as the new Covid-19 vaccination policy gets rolled out, private hospitals, states and corporate houses will be able to procure directly from manufacturers at a pre-fixed price for vaccination of those above 18 outside the central programme. However, vaccination will continue to be given free of cost to health and frontline workers and those above 45 years of age at government vaccination centres.

Meanwhile, Biological E has completed phase 1 and 2 clinical trials for its locally developed Covid-19 vaccine candidate and is likely to start phase 3 very soon. The vaccine is expected to enter the market by August.

  • Related Posts

    PGIMS recalls drug amid probe into deaths

    The PGIMS authorities have directed all departments to immediately stop using a specific batch of injectable Propofol, an anaesthetic drug, and return the available stock to the central store. The…

    NPPA list brings little relief: No price cut for 25% cancer drugs

    Mumbai: Nearly one in four cancer drug packs in a revised price list issued by the National Pharmaceutical Pricing Authority (NPPA) has seen no reduction in maximum retail price (MRP),…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

    ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

    PGIMS recalls drug amid probe into deaths

    PGIMS recalls drug amid probe into deaths

    NPPA list brings little relief: No price cut for 25% cancer drugs

    NPPA list brings little relief: No price cut for 25% cancer drugs

    Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

    Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

    For Aakash Healthcare, Community People are Apples of its Eyes

    For Aakash Healthcare, Community People are Apples of its Eyes

    Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

    Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA